OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
5.46
0.00 (0.00%)
At close: Feb 21, 2025, 4:00 PM
5.00
-0.46 (-8.42%)
After-hours: Feb 21, 2025, 4:04 PM EST
OnKure Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for OnKure Therapeutics stock have an average target of 35, with a low estimate of 32 and a high estimate of 40. The average target predicts an increase of 541.03% from the current stock price of 5.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OnKure Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 |
| Buy | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +486.08% | Jan 28, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $33 | Buy | Initiates | $33 | +504.40% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +632.60% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +632.60% | Oct 17, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $35 | Buy | Initiates | $35 | +541.03% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
510.00K
EPS This Year
-2.70
from -2.93
EPS Next Year
-3.16
from -2.70
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | 2.1M | 2.1M |
| Avg | n/a | 510,000 | 680,003 |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 311.8% |
| Avg | - | - | 33.3% |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.13 | -1.28 | -0.50 |
| Avg | -2.70 | -3.16 | -0.49 |
| Low | -4.13 | -4.88 | -0.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.